Search clinical trials for: Rosuvastatin and N-acetyl cysteine

Total 2792 results

National Institute of Allergy and Infectious Diseases...
KBio Inc

Not yet recruiting

Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults

Enterovirus Infection

United States
Tehran University of Medical Sciences

Unknown

The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient

Diabetes Mellitus Type II
Genzyme, a Sanofi Company

Terminated

A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care

Carcinoma, Hepatocellular

United States
Washington University School of Medicine

Recruiting

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes | Clonal Cytopenia of Undetermined Significance

United States
Loxo Oncology, Inc.
Eli Lilly and Company

Completed

A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants

Healthy

United States
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Helse Stavanger HF
University Hospital of North Norway; St. Olavs Hospital; Helse Vest

Completed

Microcirculation In Acute Coronary Syndromes (MICROS)

ST Elevation (STEMI) Myocardial Infarction

Norway
AstraZeneca

Completed

A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Atherosclerosis

China
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients (SD2)

Dyslipidemia

United States
Poxel SA

Completed

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Metabolic Disease

United Kingdom
University of Vermont

Completed

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (DISOLVE)

Neoplasms | Deep Vein Thrombosis | Venous Thromboembolism

United States
AstraZeneca

Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia (HYDRA)

Homozygous Familial Hypercholesterolemia (HoFH)

Malaysia, Canada, Israel, Netherlands, Taiwan, Belgium, Denmark
Queen's University
AstraZeneca

Completed

Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Dyslipidemia | Acute Coronary Syndromes

Canada
Listen Trial Group

Completed

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Hypercholesterolemia With Concomitant Type 2 Diabetes

Japan
Svendborg Hospital
University of Southern Denmark

Unknown

Intensive Statin Therapy in Patients With AMI (INTENSIFY)

Acute Myocardial Infarction

Denmark
AstraZeneca

Completed

Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

Hypercholesterolemia

China
University of Rome Tor Vergata

Completed

Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients

Type 2 Diabetes | Diabetic Dyslipidemia

Italy
AstraZeneca

Completed

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca

Completed

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Spain, Estonia, Hungary, Canada, Belgium, Portugal, Greece, Ireland, Tunisia
GlaxoSmithKline
Quintiles, Inc.

Completed

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Autoimmune Diseases

United Kingdom
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

Adverse Events | Pharmacokinetic Variables

United States
Positive Trial Group

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)

Hypertension | Type 2 Diabetes | Hypercholesterolemia

Japan
Cairo University
German University in Cairo

Recruiting

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Cisplatin Adverse Reaction

Egypt
Bjarne Linde Noergaard

Recruiting

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) (FlowPromote)

Coronary Artery Disease

Denmark
Asan Medical Center
Dong-A ST Co., Ltd.

Completed

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk (RESERVE II)

Hypertension

Korea, Republic of
Pfizer

Completed

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Healthy Volunteers

Belgium
AstraZeneca
Eli Lilly and Company

Completed

A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Healthy

United States
National Cheng-Kung University Hospital

Completed

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Diabetes Mellitus | Arteriovenous Fistula | End-stage Kidney Disease

Taiwan
GlaxoSmithKline

Completed

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Diabetes Mellitus, Type 2

United States
RenJi Hospital

Unknown

Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke (AIS)

Ischemic
Pin Siang Medical Biotechnology Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Hypercholesterolemia

Taiwan
Peking University Third Hospital

Unknown

Peking and Rotterdam on Mission to Reduce Coronary Artery Disease (PROMISS)

Diabetes Mellitus | Acute Coronary Syndrome

China
AstraZeneca

Completed

Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease (PLANET II)

Hyperlipidemia

United States, Bulgaria, South Africa, Germany, Hungary, Romania, Canada, Denmark, Mexico, Italy, Brazil
Yokohama City University Medical Center

Unknown

The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris

Coronary Disease | Hypercholesterolemia

Japan
Universidad Autonoma de San Luis Potosí

Unknown

Effect of Rosuvastatin in Abdominal Sepsis

Sepsis

Mexico
AstraZeneca

Completed

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Hypercholesteremia

Belgium
Universidad Autonoma de San Luis Potosí

Completed

Effect of Rosuvastatin in Intracerebral Hemorrhage

Stroke | Intracerebral Hemorrhage

Mexico
Ramathibodi Hospital
AstraZeneca

Unknown

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level

Systemic Lupus Erythematosus | High LDL Cholesterol Level

Thailand
AstraZeneca

Completed

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (HEROS)

Diabetes | Hypercholesterolemia | Coronary Heart Disease | Peripheral Vascular Disease | Cerebrovascular Accident
University of Colorado, Denver
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Recruiting

Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins (SPARO)

Rheumatoid Arthritis

United States
ImmunityBio, Inc.

Recruiting

A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

United States
Universiteit Antwerpen

Completed

Statins and the Urinary Proteome

Statin Induced Proteinuria

Belgium
University of Erlangen-Nürnberg Medical School
AstraZeneca

Completed

Rosuvastatin and Renal Endothelial Function

Hypercholesterolemia

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

Healthy

United Kingdom
G. d'Annunzio University
Working Group Aterosclerosi, Trombosi e Biologia Vascolare

Terminated

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty (REMEDY)

Stable Coronary Artery Disease Undergoing PCI

Italy
AstraZeneca

Withdrawn

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis (Du Lac)

Venous Thrombosis | Pulmonary Embolism
GlaxoSmithKline

Completed

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Infection, Human Immunodeficiency Virus

United States
University of British Columbia
AstraZeneca; CIHR Canadian HIV Trials Network

Terminated

Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

HIV Infections | Atherosclerosis

Canada
Merck Sharp & Dohme LLC

Completed

A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

Migraine
University of Jena
German Federal Ministry of Education and Research

Completed

Intervention With Long-chain n-3 Polyunsaturated Fatty Acids From Microalgae Oil in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Germany

3

Subscribe